✦ LIBER ✦

A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

✍ Scribed by Alan L. Robin

Book ID: 117018959
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 48 KB
Volume: 135
Category: Article
ISSN: 0002-9394
DOI: 10.1016/s0002-9394(03)00087-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Six-month randomized clinical trial comp

Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

✍ Paul S. Fellenbaum 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A six-month randomized clinical trial co

A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

✍ Robert S. Noecker; Monte S. Dirks; Neil T. Choplin; Paula Bernstein; Amy L. Bato 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Randomized clinical trial comparing intr

Randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

✍ Dan Eisenberg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 40 KB

A 3-month clinical trial comparing the I

A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma

✍ Monte S. Dirks; Robert J. Noecker; Melissa Earl; Shiyoung Roh; Steven M. Silvers 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 262 KB

A double-masked, randomized clinical tri

A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension

✍ Remo Susanna Jr.; Jair Giampani Jr.; Adriana S Borges; Roberto M Vessani; Marcel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Twelve-Month, Randomized, Controlled Tri

Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension

✍ L. Jay Katz; John S. Cohen; Amy L. Batoosingh; Carlos Felix; Vincent Shu; Rhett 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 1012 KB